NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Axil Capital Partners

Axil Capital Partners

Tokyo, Tokyoaxilcapital.com

Overview

Axil Capital is a venture capital firm specializing in investments in the biomedical and healthcare technology sectors . It focuses on funding and supporting the growth of early-stage ventures, providing financial resources and strategic guidance . Axil invests across the full spectrum of the global biotech and healthcare space, ranging from seed to crossover stage venture capital opportunities . They diversify their investments across a wide range of technologies in the life science field, including biopharmaceuticals, platform technologies, medical devices, digital health and healthcare services .

Year Founded

2017

Portfolio Companies

5

Investments

Axil Capital Partners investments
CompanyDateStageLead
Fore BiotherapeuticsJul 2026Series D-2 ExtensionCo-investor
LinqMed Inc.Jan 2025Series BCo-investor
Cellusion Inc.Jun 2023Series CLead
LUCA ScienceAug 2020Series ALead
Himuka AM Pharma Corp.Jun 2018Series ACo-investor

Key People

Yoshitake Maeda

Venture Partner

Joon Paek

Principal

Kimihito Usui

Senior Principal

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo, Tokyo
Year Founded2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.